Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Ensysce Biosciences (ENSC)

Ensysce Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ENSC
DateTimeSourceHeadlineSymbolCompany
04/02/202522:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENSCEnsysce Biosciences Inc
03/12/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENSCEnsysce Biosciences Inc
21/11/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENSCEnsysce Biosciences Inc
19/11/202419:19Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ENSCEnsysce Biosciences Inc
09/10/202420:36Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ENSCEnsysce Biosciences Inc
09/10/202420:30Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ENSCEnsysce Biosciences Inc
29/08/202420:22Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ENSCEnsysce Biosciences Inc
29/08/202418:20Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ENSCEnsysce Biosciences Inc
27/08/202419:10AllPennyStocks.comBiotech Steals The Show Following $14 Million Grant AnnouncementNASDAQ:ENSCEnsysce Biosciences Inc
23/08/202420:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENSCEnsysce Biosciences Inc
14/08/202420:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENSCEnsysce Biosciences Inc
14/08/202420:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ENSCEnsysce Biosciences Inc
28/05/202412:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENSCEnsysce Biosciences Inc
20/05/202417:05AllPennyStocks.comClinical-Stage Pharma Company Trading Higher on Continued Collaboration for Innovative Overdose TechnologyNASDAQ:ENSCEnsysce Biosciences Inc
13/05/202412:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENSCEnsysce Biosciences Inc
09/05/202420:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENSCEnsysce Biosciences Inc
15/02/202417:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ENSCEnsysce Biosciences Inc
14/02/202422:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENSCEnsysce Biosciences Inc
14/02/202411:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ENSCEnsysce Biosciences Inc
23/01/202420:45AllPennyStocks.comBiotech Soars On FDA AnnouncementNASDAQ:ENSCEnsysce Biosciences Inc
17/01/202402:56Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ENSCEnsysce Biosciences Inc
29/12/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENSCEnsysce Biosciences Inc
19/12/202321:27Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ENSCEnsysce Biosciences Inc
19/12/202321:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENSCEnsysce Biosciences Inc
30/11/202319:37Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ENSCEnsysce Biosciences Inc
29/11/202314:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENSCEnsysce Biosciences Inc
22/11/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ENSCEnsysce Biosciences Inc
17/11/202322:19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ENSCEnsysce Biosciences Inc
17/11/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENSCEnsysce Biosciences Inc
09/11/202322:06Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ENSCEnsysce Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ENSC